Lymphangiogenesis and lymphatic metastasis in breast cancer. - Test2 - elhamkhani - TriplyDB

Lymphangiogenesis and lymphatic metastasis in breast cancer.

Lymphangiogenesis and lymphatic metastasis in breast cancer.

http://www.wikidata.org/entity/Q33940058

about

Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go Lymphatic Vessels, Inflammation, and Immunity in Skin Cancer Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis The role of lymphatics in cancer as assessed by near-infrared fluorescence imaging Broad targeting of angiogenesis for cancer prevention and therapy Recent advances in lymphatic targeted drug delivery system for tumor metastasis Mouse model of lymph node metastasis via afferent lymphatic vessels for development of imaging modalities The role of lymphangiogenesis and angiogenesis in tumor metastasis Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse.A novel role for ezrin in breast cancer angio/lymphangiogenesis.RNAi-mediated gene silencing of vascular endothelial growth factor C suppresses growth and induces apoptosis in mouse breast cancer in vitro and in vivo.TIE-2 expressing monocytes in human cancers.Expression and clinical significance of matrix metalloproteinase-9 in lymphatic invasiveness and metastasis of breast cancer.Lymphatic endothelial progenitors originate from plastic myeloid cells activated by toll-like receptor-4 Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.Lymphangiogenesis in Oral Squamous Cell Carcinoma: Correlation with VEGF-C Expression and Lymph Node Metastasis.Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway Targeting lymphatic vessel functions through tyrosine kinases.Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer.New model of macrophage acquisition of the lymphatic endothelial phenotype Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner.Biomaterial guides for lymphatic endothelial cell alignment and migration Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis CXM: a new tool for mapping breast cancer risk in the tumor microenvironment.Characterization of Prox1 and VEGFR-3 expression and lymphatic phenotype in normal organs of mice lacking p50 subunit of NF-κB.Synergy of nab-paclitaxel and bevacizumab in eradicating large orthotopic breast tumors and preexisting metastases.Anti-metastasis effect of fucoidan from Undaria pinnatifida sporophylls in mouse hepatocarcinoma Hca-F cells Prognostic Significance of VEGF-C Expression in Patients with Breast Cancer: A Meta-Analysis.SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer Lymphangiogenesis and cancer Prognostic Significance of High VEGF-C Expression for Patients with Breast Cancer: An Update Meta Analysis.Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors.PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells.Relationship of CD44+CD24-/low breast cancer stem cells and axillary lymph node metastasis.Lymphangiogenesis in breast cancer is associated with non-sentinel lymph node metastases in sentinel node positive patients.Bevacizumab and breast cancer: what does the future hold?Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells.Novel model for basaloid triple-negative breast cancer: behavior in vivo and response to therapy.Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancer

P2860

Q26772925-98068276-4C58-4616-9D33-B8B2A0E84C77 Q26778332-25140084-02AD-4CEE-BD2B-FF16820B4376 Q26866144-D352C92B-4A66-41F7-93B9-75C8CC0D70FF Q27001155-A6A68163-3290-47CA-92D1-1280B7A028F8 Q27002903-F75DDBE2-3022-4946-AFC2-6795D2F5CE12 Q27005580-2DA59D24-2A47-4F59-BADE-B3C87E916653 Q27316237-E9BFC666-B593-4BDB-8E16-6394CBDDE1C1 Q28067309-C637BE0A-696E-40A2-8D3C-67BBA7082CD4 Q30499924-42A5FD3C-0F0F-45EB-9898-6038E4EE4318 Q30617722-DE898254-C95C-4CF9-913B-A4F3AB7AD757 Q32184965-46EB2636-4649-485F-A40F-7EC8E61432A4 Q33632109-E37C3FB0-F4D5-4291-90CB-D28BE7C53DE8 Q33638445-5907212C-0FE1-42E4-AE06-8399AED9087B Q33783644-2CDC540B-5756-42C9-AE26-67C7A60FCE52 Q33814571-55EB2D2B-B059-4DF1-A3F9-8FAADE401C3E Q33819978-44CA887B-2D0E-4519-8BD3-82A7A606055C Q34003819-AB711886-6AA3-42A5-B587-8FA20F2125BF Q34078275-B30AD4D1-78F8-4C9A-8CD9-A441F867CAEE Q34128977-EB0BFEB5-8F2F-4012-B044-3A51136283EB Q34143330-06EFE1BC-00EA-4659-AEED-12EDBD8DDDEB Q34187121-DA07EE20-BD0A-4EA3-AC9E-5F9BB3423D96 Q34290191-371D4D95-B57C-48CE-A61C-B8DF62930687 Q34543185-7C378142-8793-4267-981E-71B164F30224 Q34560457-BBBE3617-75C6-4980-AA08-92F654BFC2EE Q34586307-E3F09BDA-BC69-450F-B5D6-D2B1E0B9075D Q34681080-A161A246-FBCE-411E-BC5F-E572A8E247C1 Q34763649-E0922FBE-CDD5-4E26-8729-2341CCE7E1AB Q35232827-B070DDA4-422F-44C9-8C4C-B5798E629D3B Q35670023-FD3591E8-8890-453D-952E-54771FAF5632 Q35913687-B46B3755-4D1B-4F61-A9EF-B41245F91511 Q36137692-56963C1E-E0D4-404A-94F0-5216076AA9BE Q36182244-B3D63810-6A6B-4A20-85DA-95DD163A8C8C Q36198192-C4BFF7A7-02B7-4C3A-9E00-65115BD03551 Q36241115-B61229C9-4E69-4BF6-9048-1739B915E700 Q36244007-F490804F-F34D-475D-A61C-6E5B846168A1 Q36261683-0B14CF0C-8496-4495-ACC7-DDA02A6DFC55 Q36298210-16AA32BC-25CF-4B52-8253-23ABF8E10197 Q36342924-092410FF-1110-473B-8955-19ABC75D2EA2 Q36343773-776C66DA-1255-4C0A-96F5-845990AF439D Q36367559-DD32CD00-2E32-4697-8AAB-362B2C51DDA3

P2860

Lymphangiogenesis and lymphatic metastasis in breast cancer.

http://www.wikidata.org/entity/Q33940058

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Lymphangiogenesis and lymphatic metastasis in breast cancer.

@ast

Lymphangiogenesis and lymphatic metastasis in breast cancer.

@en

type

label

Lymphangiogenesis and lymphatic metastasis in breast cancer.

@ast

Lymphangiogenesis and lymphatic metastasis in breast cancer.

@en

prefLabel

Lymphangiogenesis and lymphatic metastasis in breast cancer.

@ast

Lymphangiogenesis and lymphatic metastasis in breast cancer.

@en

P1433

Q33940058-97D8AFAE-66DA-443E-850A-870CFA803D09

P1476

Q33940058-397EDE50-53A2-4F91-A823-736C0C053223

P2093

Q33940058-00EB0AC7-6517-48B5-A92D-6A55246AFF37

Q33940058-0A405717-26E3-4D7F-946C-56F7920DEBB7

Q33940058-A7E54433-93B5-466B-81D2-1BB0891A0844

Q33940058-BC219532-0EFD-42C8-8486-AE188A1E54F0

P2860

Q33940058-00C89E9D-7880-48E4-835C-3906DAF00E84

Q33940058-01C0035B-DDEE-49A7-B024-5290CAE934E5

Q33940058-0377B714-765B-4591-9A44-1AE20722A797

Q33940058-03B8609E-6C9D-4A39-B2F5-CF1A56AC1AF3

Q33940058-041B2ACB-FF7C-40CE-9EDA-D8E8BC28212B

Q33940058-060ECBDA-F232-4935-8DEC-0751A5205D1F

Q33940058-06A9CE35-B3A3-485F-BA5C-55413C6F77B7

Q33940058-0839CCDA-05E2-4412-88B6-65C11718F225

Q33940058-0BE10722-99A7-457D-A8DE-03A3B4BEF188

Q33940058-0BED1EC8-5BDF-43A1-902B-6095621AC787

P304

Q33940058-1E549CFA-0AE6-4355-ABB5-7F270343AB3D

P31

Q33940058-258FDB50-8AA2-465A-97CD-3005C488E387

P356

Q33940058-14EF81EC-4802-4EEF-BA19-FB3B66127394

P433

Q33940058-4F079EAB-F29F-4239-BF3A-3A6D6E25848D

P478

Q33940058-A8644B33-BA06-4A1E-9E5F-33AA4A23A705

P577

Q33940058-0820B087-98C0-44C8-BCAE-EC3BE23449C8

P698

Q33940058-C6B5BB95-C2C3-4075-B283-37208EEAEDA8

P921

Q33940058-E0CD09F5-244B-46D0-93A8-B8EF679C3CDB

P932

Q33940058-25A800CA-E627-42A2-8404-B99B56DD6513

P356

J.PATHOPHYS.2009.11.003

P1433

Pathophysiology

P1476

Lymphangiogenesis and lymphatic metastasis in breast cancer.

@en

P2093

Kelly Hall

http://www.w3.org/2001/XMLSchema#string

Lisa Volk

http://www.w3.org/2001/XMLSchema#string

Michael J Flister

http://www.w3.org/2001/XMLSchema#string

Sophia Ran

http://www.w3.org/2001/XMLSchema#string

P2860

LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan

Involvement of chemokine receptors in breast cancer metastasis

Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3

Endothelin-2 is a macrophage chemoattractant: implications for macrophage distribution in tumors

Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways

VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development

Biochemical characterization of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

Proteolytic processing regulates receptor specificity and activity of VEGF-C.

Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer

P304

229-251

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PATHOPHYS.2009.11.003

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20036110

http://www.w3.org/2001/XMLSchema#string

P921

lymphangiogenesis

P932

2891887

http://www.w3.org/2001/XMLSchema#string